Cancer cells expressing GOF p53 mutants, including R175H, H179I, R273H and D281G, upregulate inflammatory CXC chemokines [50], while some p53 mutants can boost TLR3-mediated cytokine expression [51]. This evidence concerns the gene TLR3 and cancer.